Semaglutide is an FDA-approved GLP-1 receptor agonist prescribed for chronic weight management in adults who are obese or overweight with at least one weight-related condition
As pointed out in an accompanying editorial by Jens Juul Holst, however, these findings may be more difficult to interpret due to several features of the study design used by Salehi and colleagues
[DOI] [PubMed] [PMC] Zhou B, Wang DD, Qiu Y, Airhart S, Liu Y, Stempien-Otero A, et al
The NAD + -consuming enzymes produce NAM as a byproduct, of which high concentrations inhibit the activity of NAD + -consuming enzymes, providing feedback regulation
Cancer Res 81:552566 Romera C, Hurtado O, Botella SH, Lizasoain I, Cardenas A, Fernandez-Tome P, Leza JC, Lorenzo P, Moro MA (2004) In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-alpha pathway